This research study will test the effectiveness of an oral medication, semaglutide, in slowing cognitive decline in people with early Alzheimer’s…
This is a randomized, double-blind, placebo-controlled, parallel-group study to verify the clinical benefit of aducanumab (BIIB037) in participants…
A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment with BAN2401 in Subjects with…
Cerevel has begun a study of an investigational drug called CVL-751 (also known as Tavapadon) as a possible treatment for Parkinson's disease. An…
The Study:
Along with our research partners at Quadrant Biosciences and Autism Speaks, we are looking for children who present signs of being on the…
A randomized, placebo-controlled, double-blind study to evaluate the effect of Sage-718 on cognitive function in participants with Huntington's…
A comparative study of Levodopa and Carbidopa bioavailability following Foslevodopa/Foscarbidopa infusion at different subcutaneous sites in…
Around 1 in 5 people inherit raised levels of a sticky particle called Lp(a) (or lipoprotein(a)) that can lead to cardiovascular disease. So if you’…
A randomized double-blind placebo-controlled phase 2 study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of…
Introduction:
The melanocortin-4 receptor (MC4R) pathway is the principal regulator of mammalian energy balance and body weight. Originating in the…